SMTL ID : 8tsb.1

Human PI3K p85alpha/p110alpha bound to compound 2

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 3.53 Å
Oligo State
hetero-1-1-mer
Ligands
1 x UIW: 5-(3-bromo-5-fluorobenzamido)-N-methyl-6-(2-methylanilino)pyridine-3-carboxamide(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Varkaris, A. et al., Discovery and Clinical Proof-of-Concept of RLY-2608, a First-in-Class Mutant-Selective Allosteric PI3K alpha Inhibitor That Decouples Antitumor Activity from Hyperinsulinemia. Cancer Discov (2024)
Release Date
2023-11-22
Peptides
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform: A
Phosphatidylinositol 3-kinase regulatory subunit alpha: B
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B

Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

Phosphatidylinositol 3-kinase regulatory subunit alpha

Related Entries With Identical Sequence

8ts7.1 | 8ts8.1 | 8ts9.1 | 8tsa.1 | 8tsc.1 | 8tsd.1